MLB report: 10,955 drug tests since 2007

4 Comments

The MLB and MLBPA jointly released a summary report of drug tests performed since 2007, stating that 10,955 took place from the start of the 2007 offseason through the beginning of this year.

The breakdown is as follows:

3,486 tests in 2008
3,722 tests in 2009 (121 in the offseason)
3,747 tests in 2010 (138 in the offseason)

I certainly wouldn’t have guessed that there were so few offseason tests. With somewhere around 1,000-1,100 players on 40-man rosters eligible to be tested, that means barely one out of every eight players is getting tested over the winter.

On the other hand, it looks like everyone is getting tested multiple times during the season.

Blue Jays place Aaron Sanchez on 10-day disabled list

Toronto Blue Jays v Los Angeles Angels of Anaheim
Getty Images
Leave a comment

The Blue Jays placed right-hander Aaron Sanchez on the 10-day disabled list with a contusion in his right index finger, per a team announcement on Saturday. The assignment is retroactive to Friday. In a corresponding move, righty Marcus Stroman was activated from the DL (right shoulder fatigue) and will take the mound for the Blue Jays at 9:07 PM ET tonight.

Sanchez, 25, is in his fifth season with the club. He hasn’t looked his sharpest so far this year, going 3-5 in 15 starts with a career-worst 4.52 ERA, 5.1 BB/9 and 7.6 SO/9 through 79 2/3 innings. It’s not yet clear how long he’ll be sidelined, though he could miss as little as one turn in the rotation before returning to the roster in the next week or two.

Sanchez isn’t the only struggling starter in Toronto’s rotation, either. Per MLB.com’s Gregor Chisholm, the team placed southpaw Jaime Garcia on the DL (right shoulder tenderness) as well, with lefty reliever Tim Mayza scheduled to take his spot on the roster. In 13 starts this season, Garcia carried a 2-6 record, 6.16 ERA, 4.5 BB/9 and 8.2 SO/9 over 61 1/3 innings. Any further decisions pertaining to the rotation — including Tuesday’s starter against the Astros — have yet to be publicly addressed.